Adenomatoid tumor

Summary

Adenomatoid tumor (MONDO:0004230) is a cancer (an umbrella term covering 5 Mondo subtypes). A subtype of mesothelioma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Umbrella term: 5 Mondo subtypes

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	adenomatoid tumor
Mondo ID	MONDO:0004230
MeSH	D018254
DOID	DOID:746
NCIT	C3762
UMLS	C0206675
MedGen	60207
Is cancer (heuristic)	yes

Also known as: adenomatoid tumor · adenomatoid tumor (morphologic abnormality) · adenomatoid tumor NOS (morphologic abnormality) · adenomatoid tumor, benign · adenomatoid tumour (morphologic abnormality) · adenomatoid tumour NOS (morphologic abnormality) · benign localized epithelial mesothelioma · benign mesothelial tumour · benign tumour of mesothelium · benign tumour of the mesothelium

Disease family

This is a subtype of mesothelioma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › mesothelial neoplasm › mesothelioma › adenomatoid tumor

Related subtypes (6): benign mesothelioma, pleural mesothelioma, well differentiated papillary mesothelioma, malignant mesothelioma, peritoneal mesothelioma, well-differentiated papillary mesothelial tumour of the pleura

Subtypes (5): uterine corpus adenomatoid tumor, fallopian tube adenomatoid tumor, epididymal adenomatoid tumor, pleural adenomatoid tumor, adenomatoid tumour of the peritoneum

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.